Study eyes role of Apple smart devices to help identify early stage AD

A study conducted by Evidation Health on behalf of Eli Lilly and Apple suggests that data collected from smart devices and digital apps might help speed up the diagnosis of early stages of Alzheimer’s disease.

The study, “Developing Measures of Cognitive Impairment in the Real World from Consumer-Grade Multimodal Sensor Streams,” was performed in order to assess the feasibility of using smart devices to differentiate individuals with mild cognitive impairment (MCI) and early Alzheimer’s disease (AD) dementia from healthy controls.

MCI is the clinically symptomatic, pre-dementia stage of AD; cognitive deficits do not yet impair the ability to function at work or in daily activities.

Full story at Medical Xpress